The effects of caffeine and d-amphetamine on spatial span task in healthy participants.

Faiz Mohammed KassimJ H Mark LimSophie V SlawikKatharina GausBenjamin PetersJoseph W Y LeeEmily K HeppleJennifer RodgerMatthew A AlbrechtMathew T Martin-Iverson

Published in: PloS one (2023)

CT-2018-CTN-02561 (Therapeutic Goods Administration Clinical Trial Registry) and ACTRN12618001292268 (The Australian New Zealand Clinical Trials Registry) for caffeine study, and ACTRN12608000610336 for d-amphetamine study.

Keyphrases

clinical trial
magnetic resonance imaging
study protocol
contrast enhanced
image quality
phase iii